Prof Susan Hilsenbeck speaks to ecancer at SABCS 2018 about modern methods of phase I trial design from a statistical and design perspective.

She says that her focus is moving forward from 3+3 designs to equally easy methods that have a better performance from a statistical perspective, and outlines the advantages of more modern methods.

Prof Hilsenbeck concludes that she feels these newer designs are an enhancement on the methods currently used.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

свернуть